Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
  • EVIP - Vaccination portal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • News & events
  • Publications & data
  • Tools
  • About us
  • Search
  1. Home
  2. Publications & data
Filter by
  • Filter by
  • Infectious disease
    • Vaccine preventable diseases (2938)
    • Respiratory diseases (1856)
    • Influenza (1158)
    • Mosquito-borne diseases (1062)
    • Food- and waterborne diseases (915)
    • Zoonosis (835)
    • Measles (693)
    • West Nile virus infection (652)
    • Sexually transmitted infections (522)
    • Tuberculosis (496)
    • Influenza in humans, seasonal (432)
    • Seasonal influenza (432)
    • Flu (432)
    • Rubella (387)
    • German measles (387)
    • Viral haemorrhagic fever (362)
    • Poliomyelitis (327)
    • HIV infection (298)
    • Human immunodeficiency virus infection (298)
    • Acquired immunodeficiency syndrome (AIDS) (298)
    • Dengue (287)
    • Viral hepatitis (287)
    • Ebola haemorrhagic fever (277)
    • Vector organisms (261)
    • Zoonotic influenza (239)
    • Avian influenza virus (228)
    • Middle East respiratory syndrome coronavirus (223)
    • Chikungunya virus disease (214)
    • Influenza A (H1N1) (214)
    • Healthcare-associated infections (202)
    • Coronavirus (199)
    • Influenza A (H1N1)2009 (197)
    • Salmonellosis (194)
    • COVID-19 (184)
    • SARS-CoV-2 (184)
    • Hepatitis A (168)
    • Nosocomial infections (128)
    • Tick-borne diseases (118)
    • Zika virus disease (113)
    • Cholera (111)
    • Legionnaires’ disease (107)
    • Mosquitoes (107)
    • Yellow fever (100)
    • Hepatitis B (99)
    • Ebola outbreak - North Kivu, Ituri, DRC (96)
    • Malaria (92)
    • Escherichia coli infection (90)
    • Campylobacteriosis (88)
    • Listeriosis (85)
    • Sandfly (84)
    • Phlebotomus (84)
    • Hepatitis C (83)
    • Influenza in humans, avian origin (81)
    • Influenza A (H9N2) (80)
    • Gonorrhoea (77)
    • Avian influenza in humans (72)
    • Shiga toxin producing Escherichia coli (STEC) infection (65)
    • Verocytotoxigenic Escherichia coli (VTEC) infection (65)
    • Multidrug-resistant tuberculosis (65)
    • Verotoxigenic Escherichia coli infection (65)
    • Hepatitis (62)
    • Ticks (61)
    • Syphilis (56)
    • Pneumococcal disease (56)
    • Invasive pneumococcal disease (56)
    • Streptococcus pneumoniae (56)
    • S. pneumoniae (56)
    • Chlamydia infection (53)
    • Whooping cough (52)
    • Invasive meningococcal disease (52)
    • Meningococcal disease (52)
    • Tick-borne encephalitis (TBE) (52)
    • Pertussis (52)
    • Vector-borne disease (49)
    • Influenza in humans, pandemic (47)
    • Botulism (44)
    • Diphtheria (44)
    • Hospital-acquired infections (43)
    • Influenza in humans, swine origin (41)
    • Enterohaemorrhagic Escherichia coli (EHEC) infection (40)
    • Shigellosis (39)
    • Anthrax (38)
    • Cryptosporidiosis (38)
    • Yersiniosis (37)
    • Crimean-Congo haemorrhagic fever (34)
    • Influenza A(H7N9) virus (34)
    • Plague (33)
    • Leptospirosis (33)
    • Mumps (33)
    • Emerging disease (33)
    • Zika virus disease - Outbreak in the Americas (33)
    • Trichinellosis (32)
    • Invasive Haemophilus influenzae disease (32)
    • Haemophilus infection (32)
    • Haemophilus influenzae type b (HiB) infection (32)
    • Community acquired infections (31)
    • Giardiasis (31)
    • Ebola outbreak - West Africa (31)
    • Brucellosis (30)
    • Vibrio (29)
    • Ebola outbreak - Equateur province, DRC (29)
    • Rift Valley fever (28)
    • Enterovirus (28)
    • Coxsackievirus (28)
    • Cutaneous warts (27)
    • Influenza A(H5N1) virus (27)
    • Hydatidosis (27)
    • Human papillomavirus infection (27)
    • Echinococcosis (27)
    • Rabies (26)
    • Q fever (24)
    • Norovirus infection (24)
    • Tularaemia (23)
    • Tetanus (22)
    • Marburg haemorrhagic fever (22)
    • Clostridium difficile infection (22)
    • Marburg virus diseases (22)
    • Paratyphoid fever (21)
    • Foodborne diseases (21)
    • Enteric fever (21)
    • Typhoid and paratyphoid fever (21)
    • Hepatitis E (19)
    • Surgical site infections (19)
    • Carbapenem-resistant Enterobactericae (19)
    • Lassa fever (18)
    • Haemorrhagic fever with renal syndrome (Puumala caused) (18)
    • Nephropathia epidemica (18)
    • Hantavirus infection (18)
    • Chickenpox (17)
    • Varicella (17)
    • Severe acute respiratory syndrome (SARS) (16)
    • Lyme disease (16)
    • Borreliosis (16)
    • Toxoplasmosis, congenital (16)
    • Lymphogranuloma venereum (15)
    • Infections in long-term care facilities (15)
    • Swine-origin influenza (15)
    • Latent tuberculosis infection (15)
    • Travel related infections (14)
    • Gastrointestinal disease (14)
    • Congenital syphilis (13)
    • Syphilis, congenital (13)
    • Extensively drug-resistant tuberculosis (XDR-TB) (13)
    • Drug-resistant tuberculosis (13)
    • Smallpox (13)
    • Variant Creutzfeldt-Jakob disease (vCJD) (12)
    • Creutzfeldt-Jakob disease (12)
    • Influenza A(H5N8) virus (12)
    • Congenital rubella (11)
    • Infections in intensive care units (11)
    • Klebsiella pneumoniae (11)
    • Haemorrhagic fever (10)
    • Snail fever (9)
    • Bilharziasis (9)
    • Schistosomiasis (9)
    • Extrapulmonary tuberculosis (9)
    • Mycobacterium chimaera (8)
    • Infections in acute care hospitals (8)
    • Influenza A(H5N2) virus (8)
    • Biting midge (8)
    • Sandfly-borne diseases (7)
    • Methicillin-resistant Staphylococcus aureus (MRSA) (7)
    • Guillain-Barré syndrome (7)
    • Influenza A(H5N6) (7)
    • Monkeypox (6)
    • Disease vector (6)
    • Louse-borne diseases (6)
    • Rotavirus infection (6)
    • Leishmaniasis (6)
    • Waterborne diseases (5)
    • Schmallenberg virus (4)
    • Acinetobacter (4)
    • Japanese encephalitis virus (3)
    • Tick-borne relapsing fever (3)
    • Febris recurrens (2)
    • Candida auris (2)
    • Arenavirus (2)
    • Rickettsiosis (2)
    • Louse borne relapsing fever (2)
    • Louse-borne typhus (1)
    • Epidemic louse-borne typhus (1)
    • Quintan fever (1)
    • Fifth disease (1)
    • Piroplasmosis (1)
    • Sindbis fever (1)
    • Trench fever (1)
    • Ventilator-associated pneumonia (1)
    • Hand, foot and mouth disease (1)
    • Erythema infectiosum (1)
    • Babesiosis (1)
    • Anaplasmosis (1)
  • Public health area
    • Surveillance (3123)
    • Public health threat (1097)
    • Outbreak (1097)
    • Threats and outbreaks (1097)
    • Prevention and control (429)
    • Disease prevention (419)
    • Prophylaxis (419)
    • Active immunisation (392)
    • Vaccination (392)
    • Immunisation (392)
    • Scientific advice (380)
    • Antimicrobial resistance (371)
    • Antibiotic resistance (371)
    • Microbiology (357)
    • Epidemiology (347)
    • Epidemic (188)
    • Determinant (175)
    • Preparedness (156)
    • Health communication (152)
    • Public health response (100)
    • Control campaign (100)
    • Molecular typing (89)
    • Vaccination coverage (85)
    • Laboratories (82)
    • Antimicrobial consumption (82)
    • Migrant health (77)
    • Laboratory based surveillance (77)
    • Diagnostic test (68)
    • Infectious diseases on aircrafts (67)
    • Travellers' health (67)
    • Preventive measure (63)
    • Training (63)
    • Transmission of disease (58)
    • Climate change (53)
    • Mass gathering (42)
    • Vaccine safety (38)
    • Laboratory quality (36)
    • Pandemic preparedness (35)
    • Epidemic intelligence (34)
    • National reference laboratory (33)
    • Reference laboratory (33)
    • Vaccine effectiveness (32)
    • Case management (26)
    • Health inequality (22)
    • Vaccine efficacy (20)
    • Burden of communicable diseases (20)
    • Hospital infection control (19)
    • Vaccine hesitancy (19)
    • Laboratory capacity (17)
    • Public health education (16)
    • Antiviral (16)
    • Whole genome sequencing (16)
    • HIV testing (16)
    • Hand hygiene (14)
    • Pregnant women (14)
    • Crisis communication (12)
    • Injecting drug users (IDUs) (12)
    • Intravenous drug users (12)
    • Antimicrobial stewardship (12)
    • People who inject drugs (PWID) (12)
    • Risk communication (12)
    • Country cooperation (12)
    • High-risk groups (11)
    • Biosafety (10)
    • Personal protective equipment (10)
    • Risk assessment guidelines for infectious diseases transmitted on aircraft (RAGIDA) (9)
    • Multidrug resistance (8)
    • Childhood vaccination (8)
    • Community engagement (8)
    • Laboratory guideline (7)
    • Health literacy (6)
    • Blood safety (6)
    • Hospital hygiene (4)
    • Point prevalence survey (4)
    • Substance of human origin (4)
    • Social marketing (3)
    • Bioterrorism (3)
    • Outbreak communication (2)
    • Health advocacy (1)
    • Intensive care unit (ICU) (1)
  • Publication series
    • Communicable Disease Threats Report (CDTR) (458)
    • Annual Epidemiological Report on Communicable Diseases in Europe (285)
    • Influenza Virus Characterisation (93)
    • Monitoring Implementation of the Dublin Declaration (49)
    • Bi-annual measles and rubella monitoring report (36)
    • Monthly measles and rubella monitoring report (36)
    • Annual Report of the Director (25)
    • Tuberculosis surveillance in Europe (24)
    • The European Union One Health Zoonoses Report (14)
    • Avian influenza overview (14)
    • HIV/AIDS Surveillance in Europe (13)
    • Antimicrobial resistance surveillance in Europe (11)
    • Gonococcal antimicrobial susceptibility surveillance in Europe (10)
    • EU summary report on AMR in zoonotic bacteria (9)
    • Legionnaires’ disease in Europe (7)
    • Core competencies (6)
    • Sexually transmitted infections in Europe (5)
    • Migrant health series (5)
    • Surveillance of antimicrobial consumption in Europe (4)
    • Surveillance of invasive bacterial diseases (4)
    • Summary of key publications (3)
    • Annual threat report (2)
    • Multi-annual programme (2)
  • Country
    • Europe (3896)
    • Africa (283)
    • Asia (233)
    • Americas (147)
    • North America (62)
    • European Neighbourhood Policy countries (43)
    • EU Candidate Countries (18)
    • Pacific regions (16)
    • Indian Ocean (14)
    • Nothern Africa (10)
    • Oceania (10)
    • ENP (6)
    • EU Potential Candidates (1)
  • Media type
    • Publication (3631)
    • Data (2460)
    • Surveillance report (1211)
    • Map (1134)
    • Peer-reviewed publication (909)
    • Table (391)
    • Technical report (367)
    • Risk assessment (346)
    • Country profile (295)
    • Graph (263)
    • Corporate publication (174)
    • Infographic (150)
    • Technical guidance (142)
    • Tool (121)
    • Meeting report (91)
    • External quality assessment (77)
    • Factsheet (71)
    • Video (60)
    • Presentation (53)
    • Mission report (41)
    • Public health guidance (28)
    • Literature review (21)
    • Leaflet (21)
    • Poster (15)
    • Expert opinion (13)
    • Communication toolkit (10)
    • Systematic review (9)
    • Toolkit (7)
    • Case definition (5)
    • News (2)
    • Epidemiological update (2)
  • All (6091)
  • Publication (3631)
  • Data (2460)
  • Page 6 of 609 // 6081 Results found
    • Sort by:

Publication

Avian influenza overview August – December 2020

Surveillance report - 11 Dec 2020

Between 15 August and 7 December 2020, 561 highly pathogenic avian influenza (HPAI) virus detections were reported in 15 EU/EEA countries and UK in wild birds, poultry and captive birds, with Germany (n=370), Denmark (n=65), the Netherlands (n=57) being the most affected countries.

Avian influenza overview August – December 2020 - EN - [PDF-3.05 MB]
  • Avian influenza virus
  • EU/EEA
  • Influenza
  • Influenza in humans, avian origin
  • Surveillance

Publication

Communicable disease threats report, 6-12 December 2020, week 50

Publication - 11 Dec 2020

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 6-12 December 2020 and includes updates on COVID-19, measles, and seasonal influenza.

Communicable disease threats report, 6-12 December 2020, week 50 - EN - [PDF-856.88 KB]
  • Coronavirus
  • COVID-19
  • Influenza
  • Influenza in humans, seasonal
  • Measles
  • Public health threat

Publication

Coronavirus disease 2019 (COVID-19) and supply of substances of human origin in the EU/EEA - Second update

Technical report - 10 Dec 2020

This second update of the original document integrates the experience of maintaining safe and sufficient supply of substances of human origin (SoHO) gained in the course of the COVID-19 pandemic and through recent scientific developments in understanding the evolution of the disease.

Coronavirus disease 2019 (COVID-19) and supply of substances of human origin in the EU/EEA - second update - EN - [PDF-854.2 KB]
  • Coronavirus
  • COVID-19
  • Healthcare-associated infections
  • Prevention and control
  • Public health threat
  • Scientific advice

Publication

Influenza virus characterisation - Summary Europe, November 2020

Surveillance report - 8 Dec 2020

This is the second report for the 2020–2021 influenza season. As of week 48/2020, only 288 influenza detections across the WHO European Region had been reported to TESSy; 52% type A viruses, with A(H3N2) prevailing over A(H1N1)pdm09, and 48% type B viruses with only two having been ascribed to a lineage, both being B/Victoria. This represents a 96% drop in detections compared to the same period in 2019, probably due to the COVID-19 pandemic and measures introduced to combat it.

Influenza virus characterisation, November 2020 - EN - [PDF-2.16 MB]
  • EU/EEA
  • Influenza
  • Influenza in humans, seasonal
  • Surveillance

Publication

Rapid Risk Assessment: Risk of COVID-19 transmission related to the end-of-year festive season

Risk assessment - 4 Dec 2020

This document assesses the risk of SARS-CoV-2 transmission to the general population and medically vulnerable individuals in the EU/EEA and the UK, from the perspective of the upcoming end-of-year festive season.

Rapid Risk Assessment: Risk of COVID-19 transmission related to the end-of-year festive season - EN - [PDF-1.33 MB]
  • Coronavirus
  • COVID-19
  • EU/EEA
  • Public health threat
  • Scientific advice
  • United Kingdom

Publication

Communicable disease threats report, 29 November-5 December 2020, week 49

Publication - 4 Dec 2020

The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period 29 November-5 December 2020 and includes updates on COVID-19, Legionnaires' disease, polio, seasonal influenza and Middle East respiratory syndrome coronavirus (MERS-CoV).

Communicable disease threats report, 29 November-5 December 2020, week 49 - EN - [PDF-1.43 MB]
  • Coronavirus
  • COVID-19
  • EU/EEA
  • Influenza in humans, seasonal
  • Legionnaires’ disease
  • Middle East
  • Middle East respiratory syndrome coronavirus
  • Poliomyelitis
  • Portugal
  • Public health threat

Data

Infographic: Preventing COVID-19 transmission during the festive season

Infographic - 4 Dec 2020

Holidays are important, but your health and that of your loved ones, especially those that are more vulnerable, should come first during this period. This infographic offers advice on how to make the holidays safer.

  • Coronavirus
  • COVID-19
  • Prevention and control
  • Public health threat

Publication

Country visit to Portugal to discuss policies relating to antimicrobial resistance

Mission report - 3 Dec 2020

ECDC and the European Commission's Directorate-General for Health and Food Safety were invited by the Portuguese authorities to carry out jointly a country visit from 2 to 6 December 2019. The visit followed-up on the Commission's One Health Action Plan against antimicrobial resistance (AMR) published on 29 June 2017, and reviewed the current status of efforts to tackle AMR in Portugal, in particular the development and implementation of national strategies and policies against AMR based on a One Health approach.

ECDC and European Commission country visit to Estonia to discuss policies relating to antimicrobial resistance - EN - [PDF-727.01 KB]
  • Antimicrobial resistance
  • Portugal

Publication

Overview of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA and the UK

Technical report - 2 Dec 2020

This document outlines the initial developments in EU/EEA member states and the UK regarding vaccine deployment plans and national vaccination strategies for COVID-19 vaccines, including interim considerations for priority groups, evidence to be considered for the prioritisation of target groups, logistical considerations and monitoring systems for post-marketing surveillance (e.g. vaccine coverage, safety, effectiveness and acceptance).

Overview of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA and the UK - EN - [PDF-629.04 KB]
  • Coronavirus
  • COVID-19
  • EU/EEA
  • Immunisation
  • Public health threat
  • Scientific advice
  • United Kingdom

Publication

Guidelines for COVID-19 testing and quarantine of air travellers - Addendum to the Aviation Health Safety Protocol

Technical report - 2 Dec 2020

This joint ECDC-European Union Aviation Safety Agency (EASA) document aims to support Member States in determining a coordinated approach to reduce the risks related to the movement of people by air within and between the EU/EEA countries and the UK in the context of the COVID-19 pandemic and current advice on avoiding non-essential travel.

Guidelines for COVID-19 testing and quarantine of air travellers - Addendum to the Aviation Health Safety Protocol - EN - [PDF-1.01 MB]
  • Coronavirus
  • COVID-19
  • EU/EEA
  • Public health threat
  • Scientific advice
  • Travellers' health
  • United Kingdom

Pagination

  • First page « First
  • Previous page ‹‹
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Current page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Next page ››
  • Last page Last »
  • About us

    • What we do
    • Who we are
    • Governance
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy data
  • Personal data protection
  • Language policy
  • Cookie policy
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2021
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
    • EVIP - Vaccination portal
  • Home
  • All topics: A to Z
  • News & events
  • Publications & data
  • Tools
  • About us